LINK:  https://bswhealth.webex.com/bswhealth/j.php?MTID=m2481b2fd483bf1fcd0bf3209a012afa8

OBJECTIVES: Upon completion of this activity, the participant should be able to:

1. Identify the role of inflammation CAD

2. Review the studies of anti-inflammatory agents on atherosclerotic diseases

3. Discuss the mechanism of colchicine

4. Discuss the results of LoDoCo2

 

FACULTY DISCLOSURE:  Patrick T. Strickland, MD, have no relevant financial relationship(s) with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.


PLANNER DISCLOSURE: Michael Sills, MD and Art Signo, RN have no relevant financial relationship(s) to disclose with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.


ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.


DESIGNATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For information, please contact Art Signo at Art.Signo@BSWHealth.org

 

Session date: 
08/01/2022 - 12:00pm to 1:00pm CDT
Location: 
Baylor Heart & Vascular Hospital - Dallas
621 North Hall Street
Meet Weekly Mondays - 1st Floor Classroom A&B
Dallas, TX 75226
United States
  • 1.00 AMA PRA Category 1 Credit
    The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
  • 1.00 Attendance
Please login or register for this course.